{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:45:02Z","timestamp":1788637502358,"version":"build-2803163510"},"reference-count":67,"publisher":"Impact Journals, LLC","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,8]]},"DOI":"10.18632\/oncotarget.18843","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T16:51:13Z","timestamp":1498755073000},"page":"63506-63517","source":"Crossref","is-referenced-by-count":23,"title":["Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies"],"prefix":"10.18632","volume":"8","author":[{"given":"Ashley","family":"Vardon","sequence":"first","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Dandapani","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Cheng","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cheng","sequence":"additional","affiliation":[{"name":"Bio-Cancer Treatment International Ltd, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"De Santo","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Mussai","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,6,29]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","article-title":"Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study","volume":"15","author":"Minicozzi","year":"2014","journal-title":"Lancet Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1158\/1055-9965.EPI-14-0207","article-title":"Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review","volume":"23","author":"Scheurer","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2350\/15-07-1666-MISC.1","article-title":"The evolution of Pediatric Soft Tissue Sarcoma Classification in the LAst 50 Years","volume":"18","author":"Coffin","year":"2015","journal-title":"Pediatr Dev Pathol"},{"key":"4","first-page":"i4351","article-title":"Long term cause specific mortalit among 34489 five year survivors of childhood cancer in Great Britain: population based cohort study","volume":"354","author":"Hawkins","year":"2016","journal-title":"BMJ"},{"key":"5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"Bouffet","year":"2006","journal-title":"Lancet Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ijc.30051","article-title":"Molecular basis and current strategies of therapeutic arginine depletion for cancer","volume":"139","author":"Mussai","year":"2016","journal-title":"Int J Cancer"},{"key":"7","unstructured":"R2: microarray analysis and visualization platform\u2019. http:\/\/r2.amc.nl."},{"key":"8","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","article-title":"Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma","volume":"29","author":"Gajjar","year":"2011","journal-title":"J Clin Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1158\/0008-5472.CAN-09-2307","article-title":"Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology","volume":"69","author":"van der Spek","year":"2009","journal-title":"Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","article-title":"Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease","volume":"28","author":"Zhao","year":"2010","journal-title":"J Clin Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccell.2016.02.001","article-title":"Atypical teratoid\/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes","volume":"29","author":"Gr\u00f6bner","year":"2016","journal-title":"Cancer Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/neuonc\/nor140","article-title":"High expression of BMP pathway genes distinguishes a subset of atypical teratoid\/rhabdoid tumors associated with shorter survival","volume":"13","author":"Foreman","year":"2011","journal-title":"Neuro Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.4049\/jimmunol.0902811","article-title":"Immune gene and cell enrichment is associated with a good prognosis in ependymoma","volume":"183","author":"Foreman","year":"2009","journal-title":"J Immunol"},{"key":"14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature09173","article-title":"Cross-species genomics matches driver mutations and cell compartments to model ependymoma","volume":"466","author":"Mack","year":"2010","journal-title":"Nature"},{"key":"15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","article-title":"New brain tumor entities emerge from molecular classification of CNS-PNETs","volume":"164","author":"Allen","year":"2016","journal-title":"Cell"},{"key":"16","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/neuonc\/nor070","article-title":"Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma","volume":"13","author":"Coyle","year":"2011","journal-title":"Neuro Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2005.04.4974","article-title":"Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations","volume":"24","author":"Gajjar","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"18","first-page":"e3088","article-title":"Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features","volume":"28","author":"Grajkowska","year":"2008","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1158\/1535-7163.MCT-09-0774","article-title":"Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma","volume":"9","author":"Hirohashi","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"20","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","article-title":"Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents","volume":"17","author":"Cleton-Jansen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/gcc.21956","article-title":"Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data","volume":"51","author":"Cleton-Jansen","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ng.1085","article-title":"Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma","volume":"44","author":"Picci","year":"2012","journal-title":"Nat Genet"},{"key":"23","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1200\/JCO.2008.19.2542","article-title":"Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome","volume":"27","author":"Picci","year":"2009","journal-title":"J Clin Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1158\/0008-5472.CAN-05-4578","article-title":"Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas","volume":"66","author":"Anderson","year":"2006","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2014-09-600643","article-title":"Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target","volume":"125","author":"De Santo","year":"2015","journal-title":"Blood"},{"key":"26","doi-asserted-by":"crossref","first-page":"e73866","DOI":"10.1371\/journal.pone.0073866","article-title":"Overexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissue","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"27","doi-asserted-by":"crossref","first-page":"50000","DOI":"10.1074\/jbc.M305903200","article-title":"Transcriptional control of the argrinine\/lysine transporter, cat-1, by physiological stress","volume":"278","author":"Hatzoglou","year":"2003","journal-title":"J Biol Chem"},{"key":"28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/BJ20060941","article-title":"A feedback transcriptional mechanism controls the levels of the arginine\/lysine transporter cat-1 during amino acid starvation","volume":"402","author":"Hatzoglou","year":"2007","journal-title":"Biochem J"},{"key":"29","first-page":"5237","article-title":"Expression of cationic amino acid transporter 2 is required for myeloid-derived suppressor cell-mediated control of T cell immunity","author":"Ratliff","year":"2015","journal-title":"J Immunol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00432-011-1050-9","article-title":"Solute carrier protein family may involve in radiation-induced radioresistance of non-small cell lung cancer","volume":"137","author":"Wang","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jdermsci.2010.12.009","article-title":"Arginine metabolism in soft tissue sarcoma","volume":"61","author":"Furue","year":"2011","journal-title":"J Dermatol Sci"},{"key":"32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1159\/000447790","article-title":"Hypoxic prolifration of osteosarcoma cells depends on arginase II","volume":"39","author":"Nelin","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.1257132","article-title":"Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1","volume":"347","author":"Zoncu","year":"2015","journal-title":"Science"},{"key":"34","doi-asserted-by":"crossref","first-page":"e973","DOI":"10.1038\/cddis.2013.475","article-title":"The ROS\/JNK\/ ATF2 pathway mediates selenite-induced leukemia NB4 cell cycle arrest and apoptosis in vitro and in vivo","volume":"4","author":"Xu","year":"2013","journal-title":"Cell Death Dis"},{"key":"35","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1158\/1078-0432.CCR-15-2539","article-title":"Polyamine antagonist therapies inhibit neuroblastoma initiation and progression","volume":"22","author":"Hayes","year":"2016","journal-title":"Clin Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","article-title":"Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment","volume":"122","author":"Cerundolo","year":"2013","journal-title":"Blood"},{"key":"37","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-14-3443","article-title":"Neuroblastoma arginase activity creates and immunosuppressive microenvironment that impairs autologous and engineered immunity","volume":"75","author":"De Santo","year":"2015","journal-title":"Cancer Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ni.1942","article-title":"Invariant NKT cells modulate the suppressive activity of Il-10-escreting neutrophils differentiated with serum amyloid A","volume":"11","author":"Asher","year":"2010","journal-title":"Nat Immunol"},{"key":"39","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1073\/pnas.0409783102","article-title":"Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination","volume":"102","author":"Bronte","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"40","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/2326-6066.CIR-15-0230","article-title":"Reduction of MDSCs with all-trans-retinoic acid improves CAR therapy efficacy for sarcomas","volume":"4","author":"Mackall","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"237ra67","DOI":"10.1126\/scitranslmed.3007974","article-title":"Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy","volume":"6","author":"Mackall","year":"2014","journal-title":"Sci Transl Med"},{"key":"42","first-page":"6413","article-title":"GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interlukin-4 receptor-\u03b1","volume":"3","author":"Okada","year":"2013","journal-title":"Cancer Res"},{"key":"43","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/stem.2393","article-title":"Cancer stem cell-secreted macrophages migration inhibitory factor stimulates myeloid derived suppressor cell function and facilitates glioblastoma immune evasion","volume":"34","author":"Jarrar","year":"2016","journal-title":"Stem Cells"},{"key":"44","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1042\/CBI20100451","article-title":"Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes","volume":"34","author":"Stasyk","year":"2010","journal-title":"Cell Biol Int"},{"key":"45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0304-4165(98)00056-7","article-title":"De novo synthesis of arginine and ornithine from citrulline in human colon carcinoma cells: meabolic fate of L-ornithine","volume":"1425","author":"Blachier","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-3002-1-12","article-title":"Reversed argininosuccinae lyase activity in fumarate hydratase-deficient cancer cells","volume":"1","author":"Gottlieb","year":"2013","journal-title":"Cancer Metabo"},{"key":"47","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1038\/cddis.2012.197","article-title":"Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblasoma","volume":"4","author":"Crook","year":"2013","journal-title":"Cell Death Dis"},{"key":"48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","article-title":"The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation","volume":"19","author":"Rauen","year":"2009","journal-title":"Curr Opin Genet Dev"},{"key":"49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-015-0288-2","article-title":"Oncogenic KRAS promotes malignant brain tumors in zebrafish","volume":"14","author":"Taylor","year":"2015","journal-title":"Mol Cancer"},{"key":"50","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/gcc.20702","article-title":"RAS signaling dysregulation in human embryonal Rhabdomyosarcoma","volume":"48","author":"Dominici","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"51","doi-asserted-by":"crossref","first-page":"e93676","DOI":"10.1371\/journal.pone.0093676","article-title":"Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors","volume":"9","author":"Kurzrock","year":"2014","journal-title":"PLoS One"},{"key":"52","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1755-148X.2010.00798.x","article-title":"Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis","volume":"24","author":"Leung","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-8722-5-17","article-title":"Deprivation of arginine by recombinant human arginase in prostate cancer cells","volume":"5","author":"Sueh","year":"2012","journal-title":"J Hematol Oncol"},{"key":"54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10637-012-9807-9","article-title":"A phase 1 dose-escalating study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma","volume":"31","author":"Poon","year":"2013","journal-title":"Invest New Drugs"},{"key":"55","first-page":"496","article-title":"Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 2 in patients with advanced hepatocellular carcinoma","author":"Poon","year":"2015","journal-title":"Invest New Drugs"},{"key":"56","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1078-0432.CCR-14-2610","article-title":"Phase I trial of arginine deprivation therapy with ADI-PEG 20 plus docetaxel in patients with advanced malignant solid tumours","volume":"21","author":"Lara","year":"2015","journal-title":"Clin Cancer Res"},{"key":"57","first-page":"6310","article-title":"Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases","volume":"73","author":"Wechsler-Reya","year":"2015","journal-title":"Cancer Res"},{"key":"58","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/17460441.2016.1237939","article-title":"The development of targeted new agents to improve the outcome for children with leukemia","volume":"11","author":"Moreno","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbacli.2014.06.003","article-title":"Moleuclar profiling of childhood cancer: Biomarkers and novel therapies","volume":"1","author":"Byrne","year":"2014","journal-title":"BBA Clin"},{"key":"60","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1158\/1535-7163.MCT-09-0774","article-title":"Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastaseis in patients with osteosarcoma","volume":"9","author":"Hirohashi","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"61","doi-asserted-by":"publisher","first-page":"70832","DOI":"10.18632\/oncotarget.12225","article-title":"Reduced argininosuccinate synthetase expression in refractory sarcomas: impacts on therapeutic potential and drug resistance","volume":"7","author":"Kitano","year":"2016","journal-title":"Oncotarget"},{"key":"62","doi-asserted-by":"crossref","first-page":"e2406","DOI":"10.1038\/cddis.2016.232","article-title":"A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas","volume":"7","author":"Van Tine","year":"2016","journal-title":"Cell Death Dis"},{"key":"63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.devcel.2015.09.008","article-title":"Non-canonical Hedgehog\/AMPK-mediated control of polyamine metabolism supports neuronal and medulloblastoma cell growth","volume":"35","author":"Giangaspero","year":"2015","journal-title":"Dev Cell"},{"key":"64","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1158\/0008-5472.CAN-14-1249","article-title":"The polyamine catabolic enzyme SAT1 modulates tumorigenesis and radiation response in GBM","volume":"74","author":"Welford","year":"2014","journal-title":"Cancer Res"},{"key":"65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00726-014-1857-1","article-title":"Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organisation by impairment of b-actin arginylation","volume":"47","author":"Redowicz","year":"2015","journal-title":"Amino Acids"},{"key":"66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11060-014-1698-5","article-title":"Human recombinant arginase I (C0)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells","volume":"122","author":"Abi-Habib","year":"2015","journal-title":"J Neurooncol"},{"key":"67","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/15384047.2015.1026478","article-title":"Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo","volume":"16","author":"Maletzki","year":"2015","journal-title":"Cancer Biol Ther"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T15:49:56Z","timestamp":1596728996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,29]]},"references-count":67,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2017,9,8]]}},"alternative-id":["18843","28969007"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.18843","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,29]]}}}